| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dementia | 73 | 2023 | 2518 | 15.160 |
Why?
|
| Netherlands | 92 | 2024 | 2170 | 8.790 |
Why?
|
| Gait | 11 | 2020 | 793 | 3.900 |
Why?
|
| Population Surveillance | 23 | 2021 | 2616 | 3.610 |
Why?
|
| Alzheimer Disease | 36 | 2024 | 8037 | 3.300 |
Why?
|
| Cognition | 31 | 2024 | 6770 | 2.840 |
Why?
|
| Brain | 45 | 2024 | 26385 | 2.760 |
Why?
|
| Polyneuropathies | 5 | 2023 | 137 | 2.650 |
Why?
|
| Cognition Disorders | 18 | 2022 | 4043 | 2.630 |
Why?
|
| Parkinsonian Disorders | 6 | 2019 | 275 | 2.630 |
Why?
|
| Stroke | 42 | 2023 | 9981 | 2.550 |
Why?
|
| Aged | 182 | 2024 | 163280 | 2.360 |
Why?
|
| Dementia, Vascular | 5 | 2019 | 128 | 2.310 |
Why?
|
| Life Expectancy | 5 | 2021 | 1184 | 2.170 |
Why?
|
| Parkinson Disease | 12 | 2019 | 2775 | 2.150 |
Why?
|
| Activities of Daily Living | 8 | 2017 | 2418 | 2.010 |
Why?
|
| Risk Factors | 101 | 2023 | 72290 | 1.920 |
Why?
|
| Genome-Wide Association Study | 38 | 2024 | 12261 | 1.710 |
Why?
|
| Cerebrovascular Circulation | 8 | 2019 | 2731 | 1.700 |
Why?
|
| Cohort Studies | 68 | 2024 | 40561 | 1.690 |
Why?
|
| Middle Aged | 142 | 2024 | 213383 | 1.670 |
Why?
|
| Male | 183 | 2024 | 350118 | 1.650 |
Why?
|
| Epidemiologic Research Design | 4 | 2021 | 367 | 1.640 |
Why?
|
| Retinal Vessels | 6 | 2017 | 772 | 1.620 |
Why?
|
| Magnetic Resonance Imaging | 51 | 2024 | 35421 | 1.610 |
Why?
|
| Female | 183 | 2024 | 380194 | 1.560 |
Why?
|
| Aging | 17 | 2023 | 8664 | 1.540 |
Why?
|
| Aged, 80 and over | 76 | 2023 | 57776 | 1.520 |
Why?
|
| Genetic Predisposition to Disease | 35 | 2024 | 17446 | 1.520 |
Why?
|
| Neuropsychological Tests | 26 | 2022 | 6993 | 1.480 |
Why?
|
| Cerebrovascular Disorders | 7 | 2019 | 1504 | 1.470 |
Why?
|
| Prospective Studies | 57 | 2023 | 53288 | 1.440 |
Why?
|
| Humans | 256 | 2024 | 744343 | 1.430 |
Why?
|
| Cerebral Arteries | 5 | 2018 | 494 | 1.410 |
Why?
|
| Community Health Planning | 10 | 2019 | 165 | 1.350 |
Why?
|
| Atherosclerosis | 8 | 2023 | 3445 | 1.320 |
Why?
|
| Neurofilament Proteins | 2 | 2020 | 318 | 1.280 |
Why?
|
| Cognitive Reserve | 3 | 2020 | 76 | 1.280 |
Why?
|
| Motor Skills | 4 | 2021 | 522 | 1.240 |
Why?
|
| Apolipoproteins E | 11 | 2023 | 1438 | 1.230 |
Why?
|
| Blood Pressure | 10 | 2021 | 8554 | 1.180 |
Why?
|
| Cardiovascular Diseases | 23 | 2023 | 15165 | 1.180 |
Why?
|
| Hippocampus | 10 | 2022 | 3675 | 1.130 |
Why?
|
| Brain Infarction | 4 | 2019 | 299 | 1.100 |
Why?
|
| Longitudinal Studies | 25 | 2023 | 13989 | 1.070 |
Why?
|
| Amyloid beta-Peptides | 7 | 2024 | 3587 | 1.050 |
Why?
|
| Microvessels | 3 | 2017 | 544 | 1.050 |
Why?
|
| Ischemic Attack, Transient | 3 | 2016 | 935 | 1.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2022 | 3047 | 0.980 |
Why?
|
| Follow-Up Studies | 37 | 2021 | 39050 | 0.980 |
Why?
|
| Brain Ischemia | 11 | 2016 | 3265 | 0.960 |
Why?
|
| Gait Disorders, Neurologic | 2 | 2017 | 231 | 0.950 |
Why?
|
| Akinetic Mutism | 1 | 2023 | 11 | 0.950 |
Why?
|
| Situs Inversus | 1 | 2023 | 64 | 0.930 |
Why?
|
| Cross-Sectional Studies | 33 | 2024 | 25043 | 0.930 |
Why?
|
| Incidence | 25 | 2024 | 20947 | 0.910 |
Why?
|
| tau Proteins | 4 | 2024 | 1868 | 0.900 |
Why?
|
| Independent Living | 4 | 2021 | 568 | 0.890 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2023 | 70 | 0.890 |
Why?
|
| Myoclonus | 1 | 2023 | 104 | 0.890 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2023 | 89 | 0.890 |
Why?
|
| Hypertension | 11 | 2023 | 8480 | 0.870 |
Why?
|
| Genetic Variation | 10 | 2019 | 6544 | 0.850 |
Why?
|
| Coffee | 3 | 2016 | 578 | 0.850 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2023 | 417 | 0.840 |
Why?
|
| Molecular Epidemiology | 2 | 2015 | 468 | 0.820 |
Why?
|
| Polymorphism, Single Nucleotide | 29 | 2024 | 15519 | 0.820 |
Why?
|
| Nitrates | 1 | 2023 | 265 | 0.820 |
Why?
|
| Resistin | 1 | 2022 | 170 | 0.800 |
Why?
|
| Migraine Disorders | 4 | 2019 | 1620 | 0.800 |
Why?
|
| Calcinosis | 3 | 2017 | 1499 | 0.790 |
Why?
|
| Carotid Artery Diseases | 3 | 2023 | 882 | 0.790 |
Why?
|
| Accidental Falls | 3 | 2018 | 1062 | 0.770 |
Why?
|
| Glomerular Filtration Rate | 4 | 2023 | 2170 | 0.760 |
Why?
|
| Intracranial Arteriosclerosis | 3 | 2023 | 138 | 0.750 |
Why?
|
| Clinical Medicine | 1 | 2022 | 147 | 0.750 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2012 | 437 | 0.750 |
Why?
|
| Atrial Fibrillation | 6 | 2023 | 5034 | 0.730 |
Why?
|
| Nerve Fibers, Myelinated | 6 | 2013 | 957 | 0.730 |
Why?
|
| MicroRNAs | 5 | 2024 | 3752 | 0.730 |
Why?
|
| Spirometry | 2 | 2021 | 864 | 0.720 |
Why?
|
| Smoking | 8 | 2023 | 8987 | 0.710 |
Why?
|
| Comorbidity | 12 | 2021 | 10388 | 0.680 |
Why?
|
| Arteriosclerosis | 1 | 2024 | 1092 | 0.680 |
Why?
|
| Risk | 13 | 2018 | 9687 | 0.660 |
Why?
|
| Intracranial Hemorrhages | 2 | 2014 | 855 | 0.650 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2020 | 349 | 0.640 |
Why?
|
| Risk Assessment | 20 | 2022 | 23338 | 0.640 |
Why?
|
| Proportional Hazards Models | 15 | 2020 | 12354 | 0.630 |
Why?
|
| Genetic Loci | 11 | 2023 | 2575 | 0.620 |
Why?
|
| Herpes Simplex | 1 | 2021 | 470 | 0.610 |
Why?
|
| Chronic Disease | 5 | 2020 | 9146 | 0.610 |
Why?
|
| Vegetables | 1 | 2023 | 1182 | 0.610 |
Why?
|
| Polypharmacy | 1 | 2020 | 294 | 0.600 |
Why?
|
| Chromosomes, Human, Pair 12 | 4 | 2014 | 462 | 0.600 |
Why?
|
| Parturition | 1 | 2021 | 441 | 0.590 |
Why?
|
| Granulocytes | 1 | 2019 | 548 | 0.590 |
Why?
|
| Executive Function | 5 | 2023 | 1364 | 0.590 |
Why?
|
| Venules | 2 | 2016 | 165 | 0.570 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2015 | 1573 | 0.570 |
Why?
|
| Actigraphy | 1 | 2020 | 488 | 0.560 |
Why?
|
| Diabetes Mellitus | 6 | 2024 | 5751 | 0.560 |
Why?
|
| Neurodegenerative Diseases | 2 | 2015 | 1061 | 0.550 |
Why?
|
| Sex Factors | 10 | 2021 | 10397 | 0.550 |
Why?
|
| Cerebellum | 2 | 2014 | 1488 | 0.550 |
Why?
|
| Arterioles | 2 | 2016 | 254 | 0.540 |
Why?
|
| Image Processing, Computer-Assisted | 10 | 2019 | 8949 | 0.540 |
Why?
|
| Occupations | 1 | 2018 | 517 | 0.540 |
Why?
|
| Causality | 3 | 2021 | 1275 | 0.530 |
Why?
|
| Apolipoprotein E4 | 8 | 2023 | 668 | 0.530 |
Why?
|
| Nervous System Diseases | 3 | 2018 | 1622 | 0.520 |
Why?
|
| Models, Statistical | 4 | 2019 | 5102 | 0.520 |
Why?
|
| Herpesvirus 1, Human | 1 | 2021 | 743 | 0.520 |
Why?
|
| Prevalence | 14 | 2021 | 15226 | 0.520 |
Why?
|
| Magnesium | 2 | 2021 | 813 | 0.520 |
Why?
|
| Cerebral Hemorrhage | 6 | 2023 | 2647 | 0.510 |
Why?
|
| Helicobacter pylori | 1 | 2018 | 382 | 0.510 |
Why?
|
| Helicobacter Infections | 1 | 2018 | 386 | 0.500 |
Why?
|
| Aorta, Thoracic | 3 | 2015 | 1082 | 0.490 |
Why?
|
| Immunity | 1 | 2020 | 1012 | 0.490 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2012 | 380 | 0.480 |
Why?
|
| von Willebrand Factor | 1 | 2018 | 669 | 0.480 |
Why?
|
| Brain Edema | 1 | 2018 | 617 | 0.460 |
Why?
|
| Functional Laterality | 3 | 2016 | 2290 | 0.460 |
Why?
|
| Telomere | 1 | 2020 | 910 | 0.460 |
Why?
|
| Genotype | 14 | 2022 | 12951 | 0.460 |
Why?
|
| Organ Size | 6 | 2019 | 2252 | 0.460 |
Why?
|
| Anxiety Disorders | 2 | 2016 | 2690 | 0.460 |
Why?
|
| Depression | 5 | 2023 | 7766 | 0.460 |
Why?
|
| Cerebral Cortex | 4 | 2013 | 5708 | 0.450 |
Why?
|
| Hemoglobins | 1 | 2019 | 1534 | 0.450 |
Why?
|
| Educational Status | 5 | 2021 | 2540 | 0.450 |
Why?
|
| Carotid Artery, Internal | 1 | 2015 | 445 | 0.440 |
Why?
|
| Hearing Loss | 1 | 2020 | 765 | 0.440 |
Why?
|
| Vasomotor System | 1 | 2013 | 209 | 0.440 |
Why?
|
| Disease Progression | 10 | 2024 | 13284 | 0.440 |
Why?
|
| Statistics as Topic | 1 | 2019 | 2373 | 0.440 |
Why?
|
| Intracranial Hemorrhage, Hypertensive | 1 | 2012 | 20 | 0.440 |
Why?
|
| Thyrotropin | 1 | 2016 | 849 | 0.440 |
Why?
|
| Thyroxine | 1 | 2016 | 667 | 0.430 |
Why?
|
| Renal Insufficiency | 1 | 2018 | 804 | 0.430 |
Why?
|
| Walking | 2 | 2017 | 1180 | 0.430 |
Why?
|
| Pathology, Molecular | 1 | 2015 | 326 | 0.420 |
Why?
|
| Peptide Fragments | 2 | 2015 | 5097 | 0.420 |
Why?
|
| Diabetic Neuropathies | 1 | 2015 | 400 | 0.410 |
Why?
|
| Extracellular Fluid | 1 | 2013 | 167 | 0.410 |
Why?
|
| Restless Legs Syndrome | 1 | 2015 | 228 | 0.410 |
Why?
|
| Leukoencephalopathies | 2 | 2011 | 238 | 0.400 |
Why?
|
| Cause of Death | 3 | 2016 | 3584 | 0.400 |
Why?
|
| Vasodilation | 1 | 2015 | 944 | 0.400 |
Why?
|
| Axons | 1 | 2019 | 1684 | 0.400 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2014 | 390 | 0.390 |
Why?
|
| Age Factors | 8 | 2020 | 18370 | 0.390 |
Why?
|
| Regional Blood Flow | 2 | 2012 | 1525 | 0.390 |
Why?
|
| Kidney Diseases | 3 | 2015 | 2149 | 0.390 |
Why?
|
| Research Design | 3 | 2022 | 5987 | 0.390 |
Why?
|
| Carotid Arteries | 4 | 2019 | 952 | 0.380 |
Why?
|
| Cholesterol | 4 | 2023 | 2917 | 0.380 |
Why?
|
| Lymphocytes | 1 | 2019 | 2617 | 0.380 |
Why?
|
| Beverages | 1 | 2016 | 820 | 0.370 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 1708 | 0.370 |
Why?
|
| Health Personnel | 1 | 2024 | 3218 | 0.370 |
Why?
|
| Prognosis | 12 | 2022 | 29063 | 0.360 |
Why?
|
| Prediabetic State | 1 | 2015 | 499 | 0.360 |
Why?
|
| Neoplasms | 4 | 2020 | 21683 | 0.360 |
Why?
|
| Hyperuricemia | 1 | 2013 | 211 | 0.360 |
Why?
|
| Disability Evaluation | 2 | 2014 | 1827 | 0.360 |
Why?
|
| Creatinine | 1 | 2015 | 1919 | 0.350 |
Why?
|
| Anemia | 1 | 2019 | 1506 | 0.350 |
Why?
|
| Aortic Diseases | 1 | 2015 | 742 | 0.350 |
Why?
|
| Mental Status Schedule | 3 | 2018 | 321 | 0.350 |
Why?
|
| Blood Platelets | 2 | 2024 | 2508 | 0.350 |
Why?
|
| Air Pollution | 1 | 2023 | 2286 | 0.340 |
Why?
|
| Coronary Disease | 2 | 2022 | 6077 | 0.340 |
Why?
|
| Health Status Indicators | 1 | 2014 | 969 | 0.330 |
Why?
|
| Data Interpretation, Statistical | 3 | 2015 | 2716 | 0.330 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2016 | 2305 | 0.330 |
Why?
|
| Air Pollutants | 1 | 2023 | 2817 | 0.330 |
Why?
|
| Vascular Diseases | 1 | 2017 | 1161 | 0.330 |
Why?
|
| Mortality | 1 | 2020 | 2864 | 0.330 |
Why?
|
| Health Education | 1 | 2015 | 1056 | 0.320 |
Why?
|
| Circadian Rhythm | 1 | 2020 | 2624 | 0.320 |
Why?
|
| Hypercholesterolemia | 1 | 2015 | 1151 | 0.320 |
Why?
|
| Nerve Net | 1 | 2020 | 2174 | 0.320 |
Why?
|
| Predictive Value of Tests | 8 | 2020 | 15076 | 0.310 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 5867 | 0.310 |
Why?
|
| Cost of Illness | 2 | 2015 | 1859 | 0.310 |
Why?
|
| Atrophy | 4 | 2014 | 1583 | 0.300 |
Why?
|
| Brain Mapping | 3 | 2019 | 6669 | 0.300 |
Why?
|
| Memory Disorders | 1 | 2014 | 1184 | 0.300 |
Why?
|
| Age Distribution | 4 | 2016 | 2902 | 0.300 |
Why?
|
| Early Diagnosis | 3 | 2020 | 1184 | 0.290 |
Why?
|
| Basilar Artery | 2 | 2019 | 200 | 0.290 |
Why?
|
| Aortic Valve | 1 | 2017 | 1922 | 0.290 |
Why?
|
| Diet | 4 | 2023 | 7939 | 0.280 |
Why?
|
| Polymorphism, Genetic | 3 | 2017 | 4328 | 0.280 |
Why?
|
| Severity of Illness Index | 5 | 2016 | 15540 | 0.280 |
Why?
|
| Temporal Lobe | 1 | 2014 | 1670 | 0.280 |
Why?
|
| Intermediate Filaments | 2 | 2023 | 175 | 0.270 |
Why?
|
| Cerebral Infarction | 4 | 2012 | 1011 | 0.270 |
Why?
|
| Intracranial Aneurysm | 1 | 2015 | 1197 | 0.270 |
Why?
|
| Lung | 2 | 2022 | 9856 | 0.260 |
Why?
|
| Fibrosis | 2 | 2023 | 2029 | 0.260 |
Why?
|
| Seasons | 2 | 2021 | 1493 | 0.260 |
Why?
|
| Vital Capacity | 2 | 2021 | 925 | 0.260 |
Why?
|
| Nerve Tissue Proteins | 3 | 2017 | 4462 | 0.260 |
Why?
|
| Genetic Markers | 7 | 2015 | 2634 | 0.260 |
Why?
|
| Psychomotor Performance | 3 | 2019 | 1901 | 0.250 |
Why?
|
| Diabetes Complications | 1 | 2012 | 1359 | 0.250 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2019 | 2737 | 0.250 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2012 | 2916 | 0.250 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2012 | 859 | 0.250 |
Why?
|
| Coronary Artery Disease | 6 | 2024 | 6487 | 0.250 |
Why?
|
| Linear Models | 5 | 2016 | 5952 | 0.250 |
Why?
|
| Age of Onset | 5 | 2019 | 3271 | 0.250 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 2400 | 0.250 |
Why?
|
| DNA Replication | 1 | 2011 | 1399 | 0.250 |
Why?
|
| Sleep | 1 | 2020 | 4623 | 0.240 |
Why?
|
| Aortic Valve Stenosis | 1 | 2017 | 1965 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2024 | 11725 | 0.240 |
Why?
|
| Reproducibility of Results | 7 | 2023 | 19905 | 0.240 |
Why?
|
| Memory | 4 | 2024 | 2174 | 0.240 |
Why?
|
| Population | 2 | 2016 | 142 | 0.240 |
Why?
|
| Insulin | 2 | 2023 | 6580 | 0.240 |
Why?
|
| Geriatric Assessment | 3 | 2019 | 1372 | 0.230 |
Why?
|
| Sural Nerve | 2 | 2023 | 106 | 0.230 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2023 | 2208 | 0.230 |
Why?
|
| Microcirculation | 1 | 2008 | 1286 | 0.220 |
Why?
|
| Albuminuria | 2 | 2018 | 682 | 0.220 |
Why?
|
| Multiple Sclerosis | 2 | 2016 | 3079 | 0.220 |
Why?
|
| Exercise | 3 | 2021 | 5615 | 0.220 |
Why?
|
| Motor Activity | 1 | 2013 | 2714 | 0.210 |
Why?
|
| Membrane Proteins | 4 | 2014 | 7880 | 0.210 |
Why?
|
| Biomedical Research | 1 | 2018 | 3309 | 0.210 |
Why?
|
| Neural Conduction | 1 | 2023 | 440 | 0.210 |
Why?
|
| Bone Density | 3 | 2023 | 3468 | 0.200 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 7913 | 0.200 |
Why?
|
| Case-Control Studies | 10 | 2021 | 21746 | 0.200 |
Why?
|
| Sex Distribution | 3 | 2016 | 2297 | 0.200 |
Why?
|
| Coronary Vessels | 3 | 2022 | 3107 | 0.190 |
Why?
|
| Europe | 5 | 2021 | 3339 | 0.190 |
Why?
|
| Immunoglobulin G | 3 | 2023 | 4560 | 0.190 |
Why?
|
| Unconsciousness | 1 | 2022 | 263 | 0.190 |
Why?
|
| Time Factors | 7 | 2019 | 40075 | 0.180 |
Why?
|
| Absorptiometry, Photon | 2 | 2023 | 1725 | 0.180 |
Why?
|
| Lipids | 1 | 2011 | 3305 | 0.180 |
Why?
|
| Adult | 17 | 2024 | 214055 | 0.180 |
Why?
|
| Genetic Association Studies | 2 | 2019 | 2703 | 0.180 |
Why?
|
| Adipokines | 1 | 2022 | 319 | 0.180 |
Why?
|
| Thyroid Gland | 2 | 2016 | 1173 | 0.180 |
Why?
|
| Depressive Disorder | 1 | 2012 | 3748 | 0.170 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 3966 | 0.170 |
Why?
|
| Anxiety | 1 | 2014 | 4297 | 0.170 |
Why?
|
| Odds Ratio | 7 | 2018 | 9849 | 0.170 |
Why?
|
| Meta-Analysis as Topic | 6 | 2020 | 1344 | 0.170 |
Why?
|
| Residence Characteristics | 3 | 2020 | 2050 | 0.170 |
Why?
|
| Survival Analysis | 3 | 2018 | 10252 | 0.170 |
Why?
|
| Vitamin B 12 | 1 | 2022 | 527 | 0.170 |
Why?
|
| Craniosynostoses | 1 | 2023 | 401 | 0.170 |
Why?
|
| Sarcopenia | 1 | 2024 | 368 | 0.170 |
Why?
|
| Insulin Resistance | 1 | 2012 | 3864 | 0.160 |
Why?
|
| GPI-Linked Proteins | 1 | 2020 | 434 | 0.160 |
Why?
|
| Blood Cell Count | 1 | 2019 | 403 | 0.160 |
Why?
|
| Serum | 1 | 2019 | 214 | 0.160 |
Why?
|
| Epistasis, Genetic | 2 | 2010 | 365 | 0.160 |
Why?
|
| Neurologic Examination | 2 | 2023 | 930 | 0.160 |
Why?
|
| F Factor | 1 | 2017 | 12 | 0.150 |
Why?
|
| Myocardial Infarction | 4 | 2013 | 11727 | 0.150 |
Why?
|
| Colorimetry | 1 | 2017 | 147 | 0.150 |
Why?
|
| Aryldialkylphosphatase | 1 | 2017 | 63 | 0.150 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 1157 | 0.150 |
Why?
|
| Anticoagulants | 1 | 2012 | 4599 | 0.150 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2017 | 91 | 0.140 |
Why?
|
| Ankle Brachial Index | 1 | 2017 | 154 | 0.140 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2017 | 76 | 0.140 |
Why?
|
| Alleles | 3 | 2019 | 6933 | 0.140 |
Why?
|
| Eating | 1 | 2023 | 1536 | 0.140 |
Why?
|
| Clusterin | 1 | 2016 | 72 | 0.140 |
Why?
|
| Adiponectin | 1 | 2022 | 1100 | 0.140 |
Why?
|
| Epilepsy, Generalized | 1 | 2018 | 174 | 0.140 |
Why?
|
| Retinal Vein | 1 | 2015 | 47 | 0.130 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2016 | 126 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2015 | 6538 | 0.130 |
Why?
|
| RNA, Untranslated | 1 | 2019 | 453 | 0.130 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 2 | 2015 | 292 | 0.130 |
Why?
|
| Syndrome | 1 | 2022 | 3251 | 0.130 |
Why?
|
| Body Mass Index | 4 | 2024 | 12720 | 0.130 |
Why?
|
| Antiporters | 1 | 2016 | 277 | 0.130 |
Why?
|
| Retinal Artery | 1 | 2015 | 111 | 0.130 |
Why?
|
| Fatty Liver | 1 | 2021 | 727 | 0.130 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2016 | 6038 | 0.120 |
Why?
|
| Migraine without Aura | 1 | 2015 | 83 | 0.120 |
Why?
|
| Cystatin C | 1 | 2015 | 250 | 0.120 |
Why?
|
| Leptin | 1 | 2022 | 1599 | 0.120 |
Why?
|
| Aortography | 1 | 2015 | 437 | 0.120 |
Why?
|
| Receptors, GABA-A | 1 | 2018 | 627 | 0.120 |
Why?
|
| Denmark | 1 | 2016 | 738 | 0.120 |
Why?
|
| Lumbar Vertebrae | 1 | 2023 | 1848 | 0.120 |
Why?
|
| Hypotension, Orthostatic | 1 | 2016 | 255 | 0.110 |
Why?
|
| Preventive Medicine | 1 | 2015 | 264 | 0.110 |
Why?
|
| Chromosomes, Human | 2 | 2015 | 457 | 0.110 |
Why?
|
| Skin | 2 | 2024 | 4364 | 0.110 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 7785 | 0.110 |
Why?
|
| Carotid Artery, Common | 1 | 2014 | 183 | 0.110 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 684 | 0.110 |
Why?
|
| Migraine with Aura | 1 | 2015 | 203 | 0.110 |
Why?
|
| Blood Glucose | 2 | 2019 | 6256 | 0.110 |
Why?
|
| Brain Stem Infarctions | 1 | 2012 | 32 | 0.110 |
Why?
|
| Anisotropy | 1 | 2016 | 1265 | 0.110 |
Why?
|
| Blood Pressure Determination | 1 | 2016 | 634 | 0.110 |
Why?
|
| Pericardium | 1 | 2017 | 667 | 0.110 |
Why?
|
| Neurofibrillary Tangles | 1 | 2014 | 439 | 0.110 |
Why?
|
| Antibodies, Bacterial | 1 | 2018 | 1470 | 0.100 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 851 | 0.100 |
Why?
|
| Inflammation | 3 | 2024 | 10638 | 0.100 |
Why?
|
| Action Potentials | 1 | 2019 | 1806 | 0.100 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2023 | 1519 | 0.100 |
Why?
|
| Pandemics | 2 | 2022 | 8388 | 0.100 |
Why?
|
| Receptor, EphA1 | 1 | 2011 | 20 | 0.100 |
Why?
|
| Leukocytes | 1 | 2020 | 2043 | 0.100 |
Why?
|
| Gene Frequency | 4 | 2015 | 3588 | 0.100 |
Why?
|
| Hypolipidemic Agents | 1 | 2016 | 604 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 1086 | 0.100 |
Why?
|
| Cholesterol, HDL | 2 | 2023 | 1814 | 0.100 |
Why?
|
| Athletes | 1 | 2019 | 1093 | 0.100 |
Why?
|
| Particulate Matter | 1 | 2023 | 2530 | 0.100 |
Why?
|
| Mesencephalon | 1 | 2013 | 329 | 0.100 |
Why?
|
| Retrospective Studies | 6 | 2016 | 77449 | 0.100 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 12245 | 0.100 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2010 | 75 | 0.100 |
Why?
|
| Monte Carlo Method | 1 | 2016 | 1254 | 0.100 |
Why?
|
| Retinal Diseases | 1 | 2017 | 683 | 0.100 |
Why?
|
| Psychological Tests | 1 | 2013 | 651 | 0.100 |
Why?
|
| Frontotemporal Dementia | 1 | 2014 | 248 | 0.100 |
Why?
|
| Dairy Products | 1 | 2014 | 498 | 0.100 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 4740 | 0.090 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 940 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2015 | 3327 | 0.090 |
Why?
|
| Plaque, Amyloid | 1 | 2014 | 729 | 0.090 |
Why?
|
| Primary Prevention | 1 | 2018 | 1167 | 0.090 |
Why?
|
| RNA Interference | 1 | 2019 | 2889 | 0.090 |
Why?
|
| ABO Blood-Group System | 1 | 2013 | 367 | 0.090 |
Why?
|
| Patient Selection | 1 | 2022 | 4215 | 0.090 |
Why?
|
| Algorithms | 4 | 2019 | 13881 | 0.090 |
Why?
|
| Serine Endopeptidases | 1 | 2016 | 1072 | 0.090 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 1741 | 0.090 |
Why?
|
| Basal Ganglia | 1 | 2013 | 546 | 0.090 |
Why?
|
| Triglycerides | 2 | 2023 | 2454 | 0.090 |
Why?
|
| Chromosomes, Human, X | 1 | 2011 | 296 | 0.090 |
Why?
|
| Fibrinogen | 1 | 2013 | 894 | 0.090 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 1743 | 0.090 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2011 | 294 | 0.090 |
Why?
|
| Germany | 1 | 2011 | 862 | 0.090 |
Why?
|
| Transferrin | 1 | 2010 | 295 | 0.090 |
Why?
|
| Survival Rate | 3 | 2015 | 12788 | 0.090 |
Why?
|
| Frail Elderly | 1 | 2014 | 693 | 0.090 |
Why?
|
| Antihypertensive Agents | 2 | 2016 | 2046 | 0.090 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 13102 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2017 | 2263 | 0.080 |
Why?
|
| Phenotype | 5 | 2023 | 16365 | 0.080 |
Why?
|
| Mental Health | 1 | 2022 | 3019 | 0.080 |
Why?
|
| Risk Reduction Behavior | 1 | 2015 | 1125 | 0.080 |
Why?
|
| Cholesterol, LDL | 2 | 2023 | 2356 | 0.080 |
Why?
|
| Neurons | 2 | 2010 | 9338 | 0.080 |
Why?
|
| Iron Overload | 1 | 2010 | 242 | 0.080 |
Why?
|
| Medical Audit | 1 | 2010 | 467 | 0.080 |
Why?
|
| Neural Pathways | 1 | 2019 | 2972 | 0.080 |
Why?
|
| Environmental Exposure | 1 | 2023 | 4234 | 0.080 |
Why?
|
| Pattern Recognition, Automated | 1 | 2014 | 1005 | 0.080 |
Why?
|
| Logistic Models | 2 | 2014 | 13408 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 1736 | 0.080 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2008 | 98 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2013 | 2971 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 560 | 0.080 |
Why?
|
| Child | 4 | 2020 | 77709 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2018 | 2635 | 0.080 |
Why?
|
| Heat-Shock Proteins | 1 | 2011 | 822 | 0.080 |
Why?
|
| Reaction Time | 1 | 2014 | 2097 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 20129 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2016 | 6365 | 0.070 |
Why?
|
| Liver | 1 | 2023 | 7474 | 0.070 |
Why?
|
| Computational Biology | 1 | 2019 | 3521 | 0.070 |
Why?
|
| Arthritis | 1 | 2012 | 659 | 0.070 |
Why?
|
| Dyspnea | 1 | 2015 | 1303 | 0.070 |
Why?
|
| Asia | 2 | 2023 | 610 | 0.070 |
Why?
|
| Observer Variation | 1 | 2013 | 2593 | 0.070 |
Why?
|
| Hand Strength | 2 | 2024 | 448 | 0.070 |
Why?
|
| Oxidative Stress | 2 | 2015 | 3086 | 0.070 |
Why?
|
| Blood Coagulation | 1 | 2013 | 1127 | 0.070 |
Why?
|
| Head | 1 | 2012 | 880 | 0.070 |
Why?
|
| Cerebral Veins | 1 | 2007 | 156 | 0.070 |
Why?
|
| Receptors, Immunologic | 1 | 2012 | 1423 | 0.070 |
Why?
|
| Fasting | 1 | 2012 | 1593 | 0.070 |
Why?
|
| Animals | 6 | 2023 | 168757 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2016 | 6459 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2022 | 9438 | 0.070 |
Why?
|
| Reference Values | 1 | 2013 | 4982 | 0.070 |
Why?
|
| Depressive Disorder, Major | 1 | 2023 | 4644 | 0.070 |
Why?
|
| Electrocardiography | 3 | 2023 | 6442 | 0.070 |
Why?
|
| Haplotypes | 1 | 2012 | 2779 | 0.070 |
Why?
|
| Receptors, Androgen | 1 | 2011 | 1058 | 0.060 |
Why?
|
| Data Collection | 1 | 2014 | 3341 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 1364 | 0.060 |
Why?
|
| Cerebrospinal Fluid | 1 | 2008 | 534 | 0.060 |
Why?
|
| Cell Line | 1 | 2019 | 15997 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2017 | 3279 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1602 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2015 | 3494 | 0.060 |
Why?
|
| Recurrence | 1 | 2016 | 8340 | 0.060 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 3086 | 0.060 |
Why?
|
| Adolescent | 5 | 2020 | 85781 | 0.060 |
Why?
|
| Health Behavior | 1 | 2016 | 2636 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14557 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 14722 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2010 | 1366 | 0.060 |
Why?
|
| Overweight | 1 | 2015 | 2371 | 0.060 |
Why?
|
| Hippurates | 1 | 2023 | 16 | 0.060 |
Why?
|
| Coronary Angiography | 1 | 2015 | 4577 | 0.060 |
Why?
|
| Metabolomics | 2 | 2023 | 1484 | 0.060 |
Why?
|
| Self Report | 1 | 2014 | 3558 | 0.060 |
Why?
|
| Enteroendocrine Cells | 1 | 2024 | 65 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2009 | 4186 | 0.060 |
Why?
|
| Gene Expression | 1 | 2016 | 7799 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2012 | 2564 | 0.060 |
Why?
|
| Parents | 1 | 2017 | 3407 | 0.060 |
Why?
|
| Models, Biological | 1 | 2019 | 9583 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2013 | 2585 | 0.050 |
Why?
|
| Antipsychotic Agents | 1 | 2016 | 3057 | 0.050 |
Why?
|
| Peripheral Nervous System | 1 | 2023 | 150 | 0.050 |
Why?
|
| Health Surveys | 1 | 2012 | 4037 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 3508 | 0.050 |
Why?
|
| Blood Cells | 1 | 2024 | 309 | 0.050 |
Why?
|
| Iceland | 2 | 2012 | 183 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 3768 | 0.050 |
Why?
|
| Ruminococcus | 1 | 2021 | 12 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 12072 | 0.050 |
Why?
|
| Computers | 1 | 2023 | 612 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2023 | 12208 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2020 | 41006 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 5853 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18029 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2011 | 4026 | 0.050 |
Why?
|
| Developing Countries | 1 | 2013 | 2815 | 0.050 |
Why?
|
| Kidney | 2 | 2023 | 7186 | 0.050 |
Why?
|
| Vitamin A | 1 | 2023 | 615 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 992 | 0.040 |
Why?
|
| Muscle Strength | 1 | 2024 | 592 | 0.040 |
Why?
|
| Genomics | 1 | 2015 | 5720 | 0.040 |
Why?
|
| Quality Control | 1 | 2022 | 841 | 0.040 |
Why?
|
| Pregnancy | 1 | 2020 | 29144 | 0.040 |
Why?
|
| Skull | 1 | 2023 | 813 | 0.040 |
Why?
|
| Amyloid | 1 | 2023 | 795 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2023 | 1537 | 0.040 |
Why?
|
| Epigenomics | 1 | 2024 | 903 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 9648 | 0.040 |
Why?
|
| Young Adult | 4 | 2018 | 56430 | 0.040 |
Why?
|
| Metagenome | 1 | 2021 | 418 | 0.040 |
Why?
|
| DNA | 1 | 2011 | 7301 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2024 | 1352 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 954 | 0.040 |
Why?
|
| Asthma | 1 | 2016 | 6011 | 0.040 |
Why?
|
| Adipocytes | 1 | 2024 | 1184 | 0.040 |
Why?
|
| Proton Pump Inhibitors | 1 | 2021 | 526 | 0.040 |
Why?
|
| Diabetic Nephropathies | 1 | 2024 | 984 | 0.040 |
Why?
|
| Metabolome | 1 | 2023 | 895 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2024 | 1194 | 0.040 |
Why?
|
| Mice | 2 | 2023 | 81183 | 0.030 |
Why?
|
| Linkage Disequilibrium | 2 | 2012 | 1997 | 0.030 |
Why?
|
| Stroop Test | 1 | 2015 | 62 | 0.030 |
Why?
|
| DNA, Intergenic | 1 | 2016 | 107 | 0.030 |
Why?
|
| Cultured Milk Products | 1 | 2014 | 6 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2016 | 287 | 0.030 |
Why?
|
| United States | 1 | 2022 | 69872 | 0.030 |
Why?
|
| Infant | 2 | 2018 | 35136 | 0.030 |
Why?
|
| Databases, Genetic | 2 | 2012 | 1783 | 0.030 |
Why?
|
| Heart | 1 | 2008 | 4467 | 0.030 |
Why?
|
| Thyroid Hormones | 1 | 2016 | 390 | 0.030 |
Why?
|
| New Zealand | 1 | 2014 | 355 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2019 | 6196 | 0.030 |
Why?
|
| Russia | 1 | 2014 | 408 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2183 | 0.030 |
Why?
|
| Cross-Cultural Comparison | 1 | 2017 | 651 | 0.030 |
Why?
|
| Quality of Life | 1 | 2015 | 12804 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 1863 | 0.030 |
Why?
|
| Family Health | 1 | 2018 | 1282 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2020 | 906 | 0.030 |
Why?
|
| Peripheral Arterial Disease | 1 | 2024 | 1188 | 0.030 |
Why?
|
| Calibration | 1 | 2014 | 816 | 0.030 |
Why?
|
| Chromatin | 1 | 2024 | 2934 | 0.030 |
Why?
|
| Diet, Fat-Restricted | 1 | 2014 | 320 | 0.030 |
Why?
|
| Heart Rate | 1 | 2023 | 4091 | 0.030 |
Why?
|
| Chaperonins | 1 | 2011 | 62 | 0.030 |
Why?
|
| Zebrafish | 1 | 2023 | 2994 | 0.030 |
Why?
|
| International Cooperation | 1 | 2018 | 1420 | 0.030 |
Why?
|
| Milk | 1 | 2014 | 450 | 0.030 |
Why?
|
| Life Style | 1 | 2023 | 3835 | 0.030 |
Why?
|
| Glucose | 1 | 2023 | 4397 | 0.020 |
Why?
|
| Muscle Weakness | 1 | 2014 | 413 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2019 | 2480 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2024 | 3479 | 0.020 |
Why?
|
| Interleukin-1alpha | 1 | 2010 | 84 | 0.020 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2011 | 200 | 0.020 |
Why?
|
| Locus Coeruleus | 1 | 2010 | 176 | 0.020 |
Why?
|
| Iron Chelating Agents | 1 | 2010 | 139 | 0.020 |
Why?
|
| Africa | 1 | 2011 | 673 | 0.020 |
Why?
|
| Spain | 1 | 2010 | 465 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2018 | 5456 | 0.020 |
Why?
|
| Movement Disorders | 1 | 2011 | 445 | 0.020 |
Why?
|
| Multigene Family | 1 | 2011 | 1102 | 0.020 |
Why?
|
| Adiposity | 1 | 2017 | 1807 | 0.020 |
Why?
|
| Fatigue | 1 | 2014 | 1531 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 2804 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2014 | 1609 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2011 | 1169 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 6895 | 0.020 |
Why?
|
| Weight Loss | 1 | 2014 | 2622 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 1903 | 0.010 |
Why?
|
| Obesity | 1 | 2024 | 12745 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 4803 | 0.010 |
Why?
|
| Venous Thromboembolism | 1 | 2013 | 1671 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2010 | 3200 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2018 | 25625 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2013 | 7729 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2009 | 3444 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2011 | 13033 | 0.010 |
Why?
|